new innate immune cells
new innate immune cells, Total:41 items.
The international standard classification for "new innate immune cells" includes: Medical materials .
The Chinese standard classification for "new innate immune cells" includes: Animal quarantine, veterinary and epidemic prevention , Medical apparatus and devices in general .
Professional Standard - Agriculture
- 1258药典 化学药和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs Anti-Human T Cell CD3 Mouse Monoclonal Antibody
- 70药典 三部-2020 Monograph Ⅰ Prophylactic Recombinant Hepatitis B Vaccine (CHO Cell)
- 92药典 三部-2010 Chapter Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulin
- 298药典 三部-2015 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test) General 129
- 274药典 四部-2020 3500 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
- 259药典 三部-2010 Appendix Ⅹ XR Anti-human T cell immunoglobulin titer assay (lymphocytotoxicity test)
- 124药典 三部-2020 Monograph Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
- 1259药典 化学药和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs against Human T Cell Immunoglobulin
- 327药典 三部-2020 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
- 农业部1719号公告-1-2012 Live swine fever vaccine (passage cell source) (new veterinary drug registration) (three types)
- 114药典 三部-2015 Monograph Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulins
- 113药典 三部-2015 Monograph Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
- 1252药典 化学药和生物制品卷-2010 Chapter 17 Immunomodulatory Drugs 1. Immunosuppressive Drugs Rat Anti-Human T Lymphocyte CD3 Antigen Monoclonal Antibody
- 农业部1793号公告-1-2012 Inactivated Recombinant Avian Influenza Virus (H5N1 Subtype) Vaccine (Cell Source, Re-5 Strain) (New Veterinary Drug Registration) (Class III)
- 农业部公告第1793号 New veterinary drug: Recombinant avian influenza virus (H5N1 subtype) inactivated vaccine (cell source, Re-5 strain)
- 279药典 四部-2015 3500 Biological activity-potency assay 3516 Anti-human T cell immunoglobulin potency assay (lymphocytotoxicity test)
- 91药典 三部-2010 Chapter Ⅱ Therapeutic anti-human T cell porcine immunoglobulin
- 1311药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 3. Blood Products Anti-Human T Cell Immunoglobulin
- 125药典 三部-2020 Monograph Ⅱ Therapeutic Anti-human T-cell Rabbit Immunoglobulins
Group Standards of the People's Republic of China
- T/CGCPU 010-2020 Environmental requirements for the preparation of immune cell products
- T/SDHCST 008-2023 Procedures for Immunogenicity and Immunotoxicity of the Cell Therapy Medical Products
- T/ZSA 150-2023 Management requirements for donor materials of immune cell product
- T/XSMIA 0004-2022 Quality Accreditation of Immunocyte Preparation Center
- T/CGCPU 011-2020 Quality Control Requirements for Immune Cell Products
- T/CGCPU 028-2023 Requirements for quality control on non gene modified immune cells clinical research
- T/CGCPU 027-2023 Design specifications for clinical research protocol of immunotherapy
- T/CGCPU 018-2022 Technical requirements for CD3, CD4, CD8 flow cytometric detection and verification of immune cell products
- T/CI 390-2024 The technical regulation for preparation and clinical application of immuno-cell CIK from healthy person
- T/GDMDMA 0001-2022 Interleukin 6 Detection kit (Chemiluminescent Immunoassay)
- T/SHPPA 019-2023 Guidance for the manufacturing quality management of plasmids used in the production of Immune cell therapy products
- T/CGCPU 009-2020 Control requirements for the preparation process of immune cell products
- T/ZSA 146-2023 Technical requirements for Flow Cytometry validation of CD3、CD4、CD8 of immune cell product
- T/CGCPU 019-2022 Material management requirements for immune cell product donors
Hebei Provincial Standard of the People's Republic of China
- DB13/T 5332-2021 Technical specification for clinical operation of cellular immunotherapy
Professional Standard - Commodity Inspection
- SN/T 1109-2002 Procedure of haemagglutination-inhibition test for Newcastle disease
国家食品药品监督管理局
- YY/T 1465.4-2017 Immunogenic evaluation method of medical devices-Part4:Phagocytosis of mouse peritoneal macrophages on chicken erythrocytes- Ex-vivo method
- YY/T 1465.3-2016 Immunogenic evaluation method of medical devices-Part 3：Plaque forming cells assay-Agar gel solid-phase method
国家药监局
- YY/T 1465.6-2019 Immunogenic evaluation method of medical devices―Part 6:Determination of animal spleen lymphocyte subsets by flow cytometry
American Society for Testing and Materials (ASTM)
- ASTM F1906-98(2003) Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration
- ASTM F1906-98 Standard Practice for Evaluation of Immune Responses In Biocompatibility Testing Using ELISA Tests, Lymphocyte, Proliferation, and Cell Migration
Association Francaise de Normalisation
- NF U47-221:2010 Isolation on cell culture and identification by immunofluorescence of infectious haematopoietic necrosis virus of fish.
